High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease

NCT01200329 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Gemcitabine
DRUG: Busulfan
DRUG: Melphalan
PROCEDURE: Stem Cell Transplantation
DRUG: Palifermin

Sponsor

M.D. Anderson Cancer Center